Primary Job Title Scientific Founder Primary Organization 
Avraham Pharmaceuticals
Location Brookline, Massachusetts, United States Regions Greater Boston Area, East Coast, New England Gender Male
LinkedIn View on LinkedIn
Michael Chorev, co-inventor of Ladostigil, retired from the Hebrew University where he held the Drs. Margaret and Henry Zentner chair of Pharmaceutical Chemistry. He is currently a faculty member of the Laboratory for Translational Research at the Harvard Medical School and affiliated with the Department of Medicine at Brigham and Women’s Hospital.
He is the co-inventor of Rivastigmine (Exelon®).
Chorev has co-authored over 170 scientific articles and reviews in journals, chapters in monographs and books. He has mentored close to 30 postgraduate students for their M.Sc., Ph.D. studies and post-doctoral training, and has served as a member of the Editorial Board of the Journal of Peptide Research and Biopolymers and is an Editor for Journal of Peptide Science.
Chorev received his B.Sc., M.Sc. and Ph.D. from the Hebrew University and did his Post-doctoral training at University of California, San Diego.
